000			03780nam a22004213i 4500
001			EBC6031536
003			MiAaPQ
005			20240724114113.0
006			m o d |
007			cr cnu||||||||
008			240724s2013 xx o ||||0 eng d
020			_a9781912530373 _q(electronic bk.)
020			_z9781908230201
035			_a(MiAaPQ)EBC6031536
035			_a(Au-PeEL)EBL6031536
035			_a(OCoLC)880720215
040			_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ
050		4	_aRC136.8 .C986 2013
082	0		_a616.925
100	1		_aReddehase, Matthias J.
245	1	0	_aCytomegaloviruses : _bFrom Molecular Pathogenesis to Intervention.
250			_a1st ed.
264		1	_aNorfolk : _bCaister Academic Press, _c2013.
264		4	_c©2013.
300			_a1 online resource (558 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
505	0		_aIntro -- Table of Contents -- II.1 -- II.2 -- II.2 Addendum -- II.3 -- II.4 -- II.5 -- II.6 -- II.7 -- II.8 -- II.9 -- II.10 -- II.11 -- II.12 -- II.13 -- II.14 -- II.15 -- II.16 -- II.17 -- II.18 -- II.19 -- II.20 -- II.21 -- II.22 -- II.23 -- Epilogue -- Index -- Open reading frames -- Cluster of differentiation -- CMV strains -- Antiviral drug index -- Frequently discussed molecules.
520			_aVolume 2 of a two-volume work that is an updated and upgraded 2nd-edition of 'Cytomegaloviruses: Molecular Biology and Immunology' (2006). The title 'Cytomegaloviruses: From Molecular Pathogenesis to Intervention' reflects its expanded commitment not only to cover cutting-edge basic science but also to include the translation of this to clinical science. In an interdisciplinary approach to understanding CMV disease and outlining options for prevention and treatment, leading international experts provide comprehensive and authoritative reviews on literally every aspect of current research with an unprecedented completeness, integrating research on human CMV and insights gained from experimental animal models. Volume II is more clinically-oriented, covering the immune response to CMV, the most pressing medical problems in the newborn and in transplantation patients, as well as diagnostics, the management of antiviral drug resistance, the state and future of a CMV vaccine, and the potential of using CMV as a vaccine vector to fight unrelated diseases. The book closes with a critical survey of disputed associations between CMV and atherosclerotic cardiovascular disease, certain tumors such as Glioblastoma Multiforme, and the phenomenon of 'immune senescence' in the elderly. The book is liberally illustrated with figures, most of which are in full colour. There are many tables and plentiful references which enhance the book even further making it an invaluable source of information. Essential reading for all virologists with an interest in cytomegaloviruses, for all clinicians in pediatric intensive-care medicine and at transplantation centers, for scientists working on antiviral drug and vaccine development, as well as for public health service and science funding system authorities.
588			_aDescription based on publisher supplied metadata and other sources.
590			_aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650		0	_aCytomegalovirus infections.
655		4	_aElectronic books.
776	0	8	_iPrint version: _aReddehase, Matthias J. _tCytomegaloviruses _dNorfolk : Caister Academic Press,c2013 _z9781908230201
797	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=6031536 _zClick to View
999			_c15841 _d15841